ClinicalTrials.gg
RecruitingNCT06274229DivAirCitySHUpdated Feb 23, 2024

DivAirCity Social Health Survey

An observational study in Psychological Stress, Psychological Well-Being and Pollution; Exposure, sponsored by Charite University, Berlin, Germany. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-23.

Sponsored by Charite University, Berlin, Germany · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Stress, Psychological with a site in Germany — 6 open to participants now, 7 under way, none of them phase 3. Stress, Psychological · Germany.

Started
2024
with 3 others
Observational
8 of 27
4 open now
Registered
23rd of 27
by date
Lead sponsor
8 of 27
Charite University, Berlin, Germany

Among the 27 studies in Stress, Psychological with a site in Germany, this one is one of 4 that started in 2024, is one of 8 observational ones, and was the 23rd registered.

Stress, Psychological

854 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.

Browse Stress, Psychological studies →

Open to participants now

6 of the 27 studies in Stress, Psychological with a site in Germany are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 74 Stress, Psychological studies recruiting now, 34 (46%) set no upper age limit and 36 (49%) stop at 75 or younger; 13 take children under 18; 49 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Stress, Psychological with a site in Germany, or all of them as a file.
02

Study summary

To reduce stress among urban residents, the consortium members of the European Council Horizon 2020 research program DivAirCity install different stress reducing, noise reducing and air quality improving means in the five cities of the consortium. This study measures physiological and psychological stress and health factors before and after the implementation of the project (at intervention sites) and compares the change (improvement) to the change in comparable places where no means were installed (control site).

Read the detailed description

Scientific studies show that increased stress can favor the development of e.g. high blood pressure, heart disease, mental illness, infectious diseases, headaches and sleep disorders. This means that stress causes considerable costs for western healthcare systems, including in our city and this neighbourhood. In large cities, where there are often hardly any natural green and forest areas left, depression and anxiety syndromes, for example, are more common than among the rural population.

For example, in Germany, more than three quarters of the population live in densely or moderately populated areas, while the global average is more than 50 per cent. Due to increasing urbanisation, people living in cities will be heavily dependent on urban nature, which can be a relevant health-promoting factor. Several studies have shown that natural spaces such as city parks, parks and even greenery on streets have a positive impact on the health of residents, both individually and collectively.

The European Council Horizon 2020 project DivAirCity (acronym explanation in the text below) is about making formerly busy public spaces in European cities more attractive again for residents and citizens. The aim is to redesign the spaces in such a way that people of different age groups, social classes and identities ("Div") can (once again) come together and meet in these places on a daily basis. To this end, these places are to be changed through various installations (planting trees, redesigning parks, shading, watering in summer) in such a way that the local air quality ("Air") in the cities ("City") improves significantly. This is realized on the one hand by installing air quality measuring equipment and by recording the number of people and the time they spend in these places (objective measurements).

In addition to these objective measurements, this study records the impact on psychological and physiological health that the installations (intervention) has on the residents. To this end, it will be measured how residents feel in terms of quality of life, current stress, general health, and whether they feel safe and secure in the specific place (comfort, safety and security) and whether they enjoy going there and staying there,. These measurements will take place both before (day -60 to day -30) and after (day +30 and day +60) the installment of the intervention.

Finally, we would like to know your age group, your gender and how close you live to the location of the conversion/installation. We would like to invite you to take part in this survey again after the remodelling project.

03

Conditions studied

  • Psychological Stress
  • Psychological Well-Being
  • Pollution; Exposure

Keywords

  • Traffic noise
  • Air pollution
  • General Health condition
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Residents of the five cities (18+ years of age)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must live or work at or near the installation (intervention group) or control site (control group)

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Aarhus, installation site

    Residents of Aarhus (DK), living at or nearby the site of the installed Intervention

    Other: Air pollution and noise reducing installations

  • Aarhus, control site

    Residents of Aarhus (DK), living at or nearby the control site

  • Bucharest, intervention site

    Residents of Bucharest (RO), living at or nearby the site of the installed Intervention

    Other: Air pollution and noise reducing installations

  • Bucharest, control site

    Residents of Bucharest (RO), living at or nearby the control site

  • Castelló, intervention site

    Residents of Castelló (ES), living at or nearby the site of the installed Intervention

    Other: Air pollution and noise reducing installations

  • Castelló, control site

    Residents of Castelló (ES), living at or nearby the control site

  • Orvieto, intervention site

    Residents of Orvieto (IT), living at or nearby the site of the installed Intervention

    Other: Air pollution and noise reducing installations

  • Orvieto, control site

    Residents of Orvieto (IT), living at or nearby the control site

  • Potsdam, intervention site

    Residents of Potsdam (DE), living at or nearby the site of the installed Intervention

    Other: Air pollution and noise reducing installations

  • Potsdam, control site

    Residents of Potsdam (DE), living at or nearby the control site

Interventions

  • OtherAir pollution and noise reducing installations

    A number of means to reduce traffic noise and traffic exhausts and improve air quality will be implemented at designated urban spaces (intervention sites), while other places with comparable amount of traffic and no such changes will serve as control sites.

06

What researchers measure

Primary outcomes

  1. WHO-5 Well-being Scale

    Validated Questionnaire

    Time frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented

Secondary outcomes

  1. Kessler K6 psychological distress

    Validated Questionnaire

    Time frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented

  2. ASKU questionnaire

    Validates Questionnaire for self-efficacy

    Time frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented

Other outcomes

  1. Questionnaire for General Physiological Health

    Custom-made Questionnaire

    Time frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented

  2. Questionnaire about feelings of safety and security at the site

    Custom-made Questionnaire

    Time frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2024; primary completion for Dec 2024, 10 months later.

Of 60 non-industry observational studies under Stress, Psychological, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 57. This study's planned 10 months is below that.

Counting every sponsor, half of 64 studies reached it within 23 months; a quarter within 6 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2024
First posted
Feb 23, 2024
StartEst.
Feb 20, 2024
Primary completionEst.
Dec 31, 2024
CompletionEst.
Dec 31, 2025
Last update
Feb 23, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06274229
Collaborators
Universitat Politècnica de València, Universitatea din Bucuresti, University of Aarhus, Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy, European Commission
Responsible party
Andreas Michalsen (Prof. Dr., Charite University, Berlin, Germany) — Principal investigator
First posted
Feb 23, 2024
Start date
Feb 20, 2024 (estimated)
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Feb 23, 2024

Study contacts

Farid I Kandil, PhD
Contact
farid-ihab.kandil@charite.de
+493080505 ext. 770
Etienne Hanslian, MD
Contact
etienne.hanslian@charite.de
+493080505 ext. 770
Andreas Michalsen, Prof MD
principal investigator · Charite Universitaetsmedizin Berlin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion